Reata Pharmaceuticals Inc - Class A


Market Cap$0

Compare Reata Pharmaceuticals

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Reata Pharmaceuticals Inc - Class AReata Pharmaceuticals Inc - Class A00%-100%-0.8
marketMarket Avg58.91.26%30%-1
HealthcareHealthcare Avg64.71.29%15%7.30.9

Current Fair Value

9.4% upside

Undervalued by 9.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$0.00
Enterprise Value$-257,084,000.00
Dividend Yield$0.0 (0.0%)
Earnings per Share$-2.31
Outstanding Shares33,587,596
Avg 30 Day Volume0


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
Price to Sales-
Price to Book Ratio86.18
Enterprise Value to Revenue-10.95
Enterprise Value to EBIT0.75
Enterprise Value to Net Income2
Total Debt to Enterprise-0.28
Debt to Equity0.84

Revenue Sources

No data

ESG Score

No data

About Reata Pharmaceuticals Inc

CEO: J. Warren Huff